MedTrace Logo

Post-Marketing Surveillance of Vliwazell® Prowound Dressing

NCT07316556 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2026-01-05

No results posted yet for this study

Summary

This PMCF study is conducted to confirm the effectiveness and safety of the wound dressing Vliwazell® Pro. The aim of the study is to validate the performance of Vliwazell® Pro within its intended purpose and certified indications during routine use, and to gather additional safety data. The study will examine how the use of the dressing affects the condition of the skin surrounding the wound, the wound status in terms of exudate, wound odor, and other parameters. Furthermore, the satisfaction of healthcare providers and patients with the application of the dressing will be assessed.

Conditions

  • Acute and Chronic Wounds

Sponsors & Collaborators

  • Lohmann & Rauscher

    lead INDUSTRY

Principal Investigators

  • Thomas Eberlain, Dr · Lohmann & Rauscher

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-11
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07316556 on ClinicalTrials.gov